BNP Paribas Financial Markets
IMCR icon

BNP Paribas Financial Markets’s Immunocore IMCR Stock Holding History

BNP Paribas Financial Markets’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Buy
18,999
+2,063
+12% +$61K ﹤0.01% 3648
2026
Q1 		$511K Sell
16,936
-3,246
-16% -$105K ﹤0.01% 3579
2025
Q4 		$701K Buy
20,182
+445
+2% +$15.7K ﹤0.01% 3368
2025
Q3 		$717K Sell
19,737
-18,439
-48% -$626K ﹤0.01% 3363
2025
Q2 		$1.2M Sell
38,176
-2,145
-5% -$66.6K ﹤0.01% 2799
2025
Q1 		$1.2M Sell
40,321
-152,794
-79% -$4.58M ﹤0.01% 2653
2024
Q4 		$5.7M Buy
+193,115
New +$6.11M ﹤0.01% 1699

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BNP Paribas Financial Markets's IMCR Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Immunocore (IMCR) stake by 12% in Q2 2026, buying an estimated $61K and bringing the position to 18,999 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #3648.

BNP Paribas Financial Markets first reported a position in IMCR in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.7M in Q4 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • BNP Paribas Financial Markets held 18,999 shares of Immunocore worth $603K as of Q2 2026.
  • BNP Paribas Financial Markets bought 2,063 Immunocore shares in Q2 2026, an estimated $61K.
  • Immunocore made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3648 holding.
  • BNP Paribas Financial Markets first reported a position in Immunocore in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Immunocore position peaked at $5.7M in Q4 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.